COVID vaccines not linked to seizures
On Apr. 30, 2024, a meta-analysis of six randomized controlled trials in JAMA Neurology found no increase in seizures in…
On Apr. 30, 2024, a meta-analysis of six randomized controlled trials in JAMA Neurology found no increase in seizures in…
On Apr. 29, 2024, Oregon Health Sciences University (OHSU) reported a patient with the first documented case of…
On Apr. 26, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had approved awarding nearly $31…
On Apr. 26, 2024, engineers at Washington University in St. Louis announced a new imaging technique that give…
On Mar. 18, 2024, using advanced imaging techniques and in-depth clinical assessments, a research team at the National…
On Mar. 13, 2024, researchers at the National Institutes of Health (NIH) announced they had discovered that symptoms…
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM) awarded $56 million to fund various clinical…
On Jan. 25, 2024, dozens of noted scientists, philanthropists, and Washington University, state and local leaders celebrated the…
On Jan. 9, 2024, Biogen and Eisai announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody ‘LEQEMBI’…
On Dec. 14, 2023, the University of Alberta announced that a study published in Nature sheds light on…
On Dec. 13, 2023, the Allen Institute and collaborators announced that after six years and 32 million cells,…
On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…
On Oct. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $42.1 million to fund various translational…
On Oct. 20, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved PENBRAYA (meningococcal…
On Oct. 10, 2023, the University of Wisconsin-Madison researchers announced a new study published in the journal Neuron…
On Oct. 2, 2023, the California Institute for Regenerative Medicine (CIRM) announced its approval of a new program…
On Sept. 28, 2023, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) announced…
On Aug. 23, 2023, a gene variant found almost exclusively in the genomes of people of African ancestry…
On Aug. 4, 2023, Biogen and Sage Therapeutics announced that the U.S. Food and Drug Administration (FDA) had…
On Jul. 28, 2023, in a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Healthメs…
On Jun. 17, 2023, the Mississippi man known as “Case 1,” the first person to be diagnosed with…
Milestones in Parkinson’s illustrates advancements in the disease from James Parkinson’s essay on ‘shaking palsy’ to development of…
On May 11, 2023, the U.S. Food and Drug Administration (FDA) announced the supplemental approval of Otsuka Pharmaceutical…
On Apr. 13, 2023, in an enormous leap forward in the understanding of Parkinson’s disease (PD), researchers announced…
On Feb. 28, 2023, a team from the University of Sydney reported that a flu virus found in…
On Jan. 31, 2023, a team of researchers led by the Innovation Center for Neurological Disorders and Department…
On Nov. 16, 2022, resarchers at the National Institutes of Health (NIH) announced they had successfully identified differences…
On Aug. 31, 2022, the Yale New Haven Hospital broke ground on the $838 million, 505,000 square foot…
On Jul. 28, 2022, the Allen Institute announced a newly released dataset of 1.2M cells from brain donors…
On Apr. 22, 2022, Stanford University announced it was awarded a $75 million gift from Nike co-founder Phil…